A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court.

President Joe Biden and Vice President Kamala Harris have repeatedly touted on the campaign trail their efforts to lower drug prices, including a $2,000 limit on Medicare enrollees’ out-of-pocket prescription costs that starts in January.

Medicare Part D provides prescription drug coverage for those enrolled in Medicare and can significantly help in the management of healthcare costs during retirement. However, plans are available from many private insurance companies,